Literature DB >> 9802271

Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis.

M Zwarenstein1, J H Schoeman, C Vundule, C J Lombard, M Tatley.   

Abstract

BACKGROUND: Tuberculosis is a major public-health problem in South Africa, made worse by poor adherence to and frequent interruption of treatment. Direct observation (DO) of tuberculosis patients taking their drugs is supposed to improve treatment completion and outcome. We compared DO with self-supervision, in which patients on the same drug regimen are not observed taking their pills, to assess the effect of each on the success of tuberculosis treatment.
METHODS: We undertook an unblinded randomised controlled trial in two communities with large tuberculosis caseloads. The trial included 216 adults who started pulmonary tuberculosis treatment for the first time, or who had a second course of treatment (retreatment patients). No changes to existing treatment delivery were made other than randomisation. Analysis was by intention to treat. Individual patient data from the two communities were combined.
FINDINGS: Treatment for tuberculosis was more successful among self-supervised patients (60% of patients) than among those on DO (54% of patients, difference between groups 6% [90% CI -5.1 to 17.0]). Retreatment patients had significantly more successful treatment outcomes if self-supervised (74% of patients) than on DO (42% of patients, difference between groups 32% [11%-52%]).
INTERPRETATION: At high rates of treatment interruption, self-supervision achieved equivalent outcomes to clinic DO at lower cost. Self-supervision achieved better outcomes for retreatment patients. Supportive patient-carer relations, rather than the authoritarian surveillance implicit in DO, may improve treatment outcomes and help to control tuberculosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9802271     DOI: 10.1016/S0140-6736(98)04022-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  48 in total

1.  A novel approach to directly observed therapy for tuberculosis in an HIV-endemic area.

Authors:  M Desvarieux; P R Hyppolite; W D Johnson; J W Pape
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

Review 2.  Optimizing tuberculosis control in the inner city.

Authors:  J M FitzGerald
Journal:  CMAJ       Date:  1999-03-23       Impact factor: 8.262

Review 3.  Antiretroviral therapy in Africa.

Authors:  Warren Stevens; Steve Kaye; Tumani Corrah
Journal:  BMJ       Date:  2004-01-31

4.  The challenge of sustaining effectiveness over time: the case of the global network to stop tuberculosis.

Authors:  Kathryn Quissell; Gill Walt
Journal:  Health Policy Plan       Date:  2015-08-17       Impact factor: 3.344

5.  Key challenges to achieving health for all in an inequitable society: the case of South Africa.

Authors:  David Sanders; Mickey Chopra
Journal:  Am J Public Health       Date:  2005-11-29       Impact factor: 9.308

6.  Promoting adherence to treatment for tuberculosis: the importance of direct observation.

Authors:  Thomas R Frieden; John A Sbarbaro
Journal:  Bull World Health Organ       Date:  2007-05       Impact factor: 9.408

7.  A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers.

Authors:  Kevin E Thorpe; Merrick Zwarenstein; Andrew D Oxman; Shaun Treweek; Curt D Furberg; Douglas G Altman; Sean Tunis; Eduardo Bergel; Ian Harvey; David J Magid; Kalipso Chalkidou
Journal:  CMAJ       Date:  2009-04-16       Impact factor: 8.262

8.  Caveat emptor? Meta-analysis of studies comparing self-observed therapy and directly observed therapy for tuberculosis.

Authors:  Patrick K Moonan; Stephen E Weis
Journal:  Clin Infect Dis       Date:  2013-06-27       Impact factor: 9.079

Review 9.  Problems for clinical judgement: 5. Principles of influence in medical practice.

Authors:  Donald A Redelmeier; Robert B Cialdini
Journal:  CMAJ       Date:  2002-06-25       Impact factor: 8.262

10.  Cost of illness of tuberculosis in Penang, Malaysia.

Authors:  Elfatih Ibrahim Elamin; Mohamed Izham Mohamed Ibrahim; Syed Azhar Syed Sulaiman; Abdul Razak Muttalif
Journal:  Pharm World Sci       Date:  2008-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.